SCRI

Highly Engaged Employees

Founded in 1984, SCRI serves as a global leader in oncology research, specializing in the execution of complex cancer clinical trials within community settings. The organization effectively bridges the gap between pharmaceutical innovation and patient care by collaborating extensively with biotech firms, physicians, and patients to accelerate the development of new cancer treatment science. By leveraging deep industry expertise, SCRI facilitates the transition of experimental therapies into standard clinical practice.

Operating with a workforce of 500-1,000 employees, SCRI maintains a robust infrastructure that supports over 250 locations across 24 states. This expansive network, which includes more than 1,300 research physicians, has played a pivotal role in the development of the majority of new cancer therapies currently approved by the FDA. Meet SCRI's team to understand the organizational expertise and leadership driving these critical clinical advancements and operational successes.

SCRI functions as a critical partner in the drug development lifecycle, providing strategic market research, objective coverage, and comprehensive clinical trial management services. By focusing on community-based access, the institute ensures that patients receive cutting-edge treatments close to home. The company’s commitment to high-quality data and rigorous research standards continues to influence the global oncology sector, solidifying its position as a premier entity in the business services and medical research landscape. This B2B and B2C approach ensures that research outcomes are both scientifically sound and accessible to the broader medical community.